FCGR2/3 polymorphisms are associated with susceptibility to Kawasaki disease but do not predict intravenous immunoglobulin resistance and coronary artery aneurysms.
Saved in:
| Title: | FCGR2/3 polymorphisms are associated with susceptibility to Kawasaki disease but do not predict intravenous immunoglobulin resistance and coronary artery aneurysms. |
|---|---|
| Authors: | Uittenbogaard P; Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam (UvA), Amsterdam, Netherlands., Netea SA; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (Amsterdam UMC), UvA, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, UvA, Amsterdam, Netherlands., Tanck MWT; Department of Epidemiology and Data Science, Amsterdam UMC, Location UvA, Amsterdam, Netherlands., Geissler J; Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam (UvA), Amsterdam, Netherlands., Buda P; Department of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, Warsaw, Poland., Kowalczyk-Domagała M; Department of Pediatric Cardiology, The Children's Memorial Health Institute, Warsaw, Poland., Okarska-Napierała M; Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland., van Stijn D; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (Amsterdam UMC), UvA, Amsterdam, Netherlands., Tacke CE; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (Amsterdam UMC), UvA, Amsterdam, Netherlands., Burgner DP; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, Australia.; Department of Pediatrics, University of Melbourne, Melbourne, VIC, Australia., Shimizu C; Department of Pediatrics, University of California, San Diego, La Jolla, CA, United States., Burns JC; Department of Pediatrics, University of California, San Diego, La Jolla, CA, United States., Kuipers IM; Department of Pediatric Cardiology, Amsterdam UMC, UvA, Amsterdam, Netherlands., Kuijpers TW; Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam (UvA), Amsterdam, Netherlands.; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (Amsterdam UMC), UvA, Amsterdam, Netherlands., Nagelkerke SQ; Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam (UvA), Amsterdam, Netherlands.; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (Amsterdam UMC), UvA, Amsterdam, Netherlands. |
| Corporate Authors: | US Kawasaki Disease Genetics Consortium |
| Source: | Frontiers in immunology [Front Immunol] 2024 Sep 18; Vol. 15, pp. 1323171. Date of Electronic Publication: 2024 Sep 18 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39359734 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: FCGR2/3 polymorphisms are associated with susceptibility to Kawasaki disease but do not predict intravenous immunoglobulin resistance and coronary artery aneurysms. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Uittenbogaard+P%22">Uittenbogaard P</searchLink>; Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam (UvA), Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Netea+SA%22">Netea SA</searchLink>; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (Amsterdam UMC), UvA, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, UvA, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Tanck+MWT%22">Tanck MWT</searchLink>; Department of Epidemiology and Data Science, Amsterdam UMC, Location UvA, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Geissler+J%22">Geissler J</searchLink>; Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam (UvA), Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Buda+P%22">Buda P</searchLink>; Department of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Kowalczyk-Domagała+M%22">Kowalczyk-Domagała M</searchLink>; Department of Pediatric Cardiology, The Children's Memorial Health Institute, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Okarska-Napierała+M%22">Okarska-Napierała M</searchLink>; Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22van+Stijn+D%22">van Stijn D</searchLink>; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (Amsterdam UMC), UvA, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Tacke+CE%22">Tacke CE</searchLink>; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (Amsterdam UMC), UvA, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Burgner+DP%22">Burgner DP</searchLink>; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, Australia.; Department of Pediatrics, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Shimizu+C%22">Shimizu C</searchLink>; Department of Pediatrics, University of California, San Diego, La Jolla, CA, United States.<br /><searchLink fieldCode="AU" term="%22Burns+JC%22">Burns JC</searchLink>; Department of Pediatrics, University of California, San Diego, La Jolla, CA, United States.<br /><searchLink fieldCode="AU" term="%22Kuipers+IM%22">Kuipers IM</searchLink>; Department of Pediatric Cardiology, Amsterdam UMC, UvA, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Kuijpers+TW%22">Kuijpers TW</searchLink>; Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam (UvA), Amsterdam, Netherlands.; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (Amsterdam UMC), UvA, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Nagelkerke+SQ%22">Nagelkerke SQ</searchLink>; Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam (UvA), Amsterdam, Netherlands.; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (Amsterdam UMC), UvA, Amsterdam, Netherlands. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22US+Kawasaki+Disease+Genetics+Consortium%22">US Kawasaki Disease Genetics Consortium</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Sep 18; Vol. 15, pp. 1323171. <i>Date of Electronic Publication: </i>2024 Sep 18 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39359734 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2024.1323171 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1323171 Titles: – TitleFull: FCGR2/3 polymorphisms are associated with susceptibility to Kawasaki disease but do not predict intravenous immunoglobulin resistance and coronary artery aneurysms. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Uittenbogaard P – PersonEntity: Name: NameFull: Netea SA – PersonEntity: Name: NameFull: Tanck MWT – PersonEntity: Name: NameFull: Geissler J – PersonEntity: Name: NameFull: Buda P – PersonEntity: Name: NameFull: Kowalczyk-Domagała M – PersonEntity: Name: NameFull: Okarska-Napierała M – PersonEntity: Name: NameFull: van Stijn D – PersonEntity: Name: NameFull: Tacke CE – PersonEntity: Name: NameFull: Burgner DP – PersonEntity: Name: NameFull: Shimizu C – PersonEntity: Name: NameFull: Burns JC – PersonEntity: Name: NameFull: Kuipers IM – PersonEntity: Name: NameFull: Kuijpers TW – PersonEntity: Name: NameFull: Nagelkerke SQ IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 09 Text: 2024 Sep 18 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
